Encompass Health Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Encompass Health Corporation (EHC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $35.22 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-02-26
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $35.22, a 34.74% increase from fiscal 2024.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $26.14, a 35.93% increase from fiscal 2023.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $19.23, a 11.22% increase from fiscal 2022.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $17.29, a 9.99% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2025-12-31 | $35.22 10-K · filed 2026-02-26 |
| 2024-12-31 | $26.14 10-K · filed 2026-02-26 |
| 2023-12-31 | $19.23 10-K · filed 2026-02-26 |
| 2022-12-31 | $17.29 10-K · filed 2025-02-28 |
| 2021-12-31 | $19.21 10-K · filed 2024-02-28 |
| 2020-12-31 | $15.48 10-K · filed 2023-02-27 |
| 2019-12-31 | $15.45 10-K · filed 2022-02-25 |
| 2018-12-31 | $14.57 10-K · filed 2021-02-26 |
| 2017-12-31 | $11.55 10-K · filed 2020-02-27 |
| 2016-12-31 | $11.55 10-K · filed 2019-02-27 |
| 2015-12-31 | $15.11 10-K · filed 2018-02-28 |
| 2014-12-31 | $11.41 8-K · filed 2017-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |